Effect of Dietary Fiber on Metabolic Syndrome, Gastrointestinal Function, Mood and Sleep Quality in Obese People

Chien-Wen Hou

Status: Completed

Conditions: Hypertension; Hyperglycemia; Obesity; Dyslipidemia; Metabolic Syndrome

Treatments: Dietary Supplement: Dietary Fiber Supplementation; Other: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT06626867

2021006001

Details and patient eligibility

About

Metabolic syndrome includes hypertension(high blood pressure), hyperglycemia(high blood suger), dyslipidemia(abnormal blood lipid level) and obesity. The more items that meet metabolic syndrome, the higher the risk of cardiovascular disease and diabetes, and the higher the combined mortality. At present, research reports point out that the occurrence of metabolic syndrome is related to age, obesity, lifestyle and genetics.

The lack of sleep may reduce the diversity of intestinal flora, and conversely, if the diversity of intestinal flora can be increased, the quality of sleep may be improved. Dietary fiber can improve intestinal microflora and related indexes of metabolic syndrome.

Although recent studies have demonstrated that dietary fiber will affect obesity, mood and sleep, different kinds of dietary fiber will affect different strains and pro-duce different effects. The effect of resistant starch on metabolic syndrome, mood and sleep of obese people is not very clear. Therefore, the objective of this intervention trial was to evaluate the effects of the intake of resistant starch on sleep, mood, changes in body composition and biomarkers in metabolic syndrome.

Enrollment: 27 patients

Sex: All

Ages: 30 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Obese working popu-lation aged between 30 and 45;
• Body fat is more than 25% for male and more than 30% for female

Exclusion criteria

• Taking any medicines;
• Menopausal women;
• Pregnant woman

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

27 participants in 2 patient groups, including a placebo group

placebo

Placebo Comparator group

Description:

Ingest maltodextrin

Treatment:

Other: Placebo

dietary fiber

Experimental group

Description:

Ingest indigestible dextrin supplementation

Treatment:

Dietary Supplement: Dietary Fiber Supplementation